Study of Letrozole in Recurrent Gliomas
| Status: | Recruiting |
|---|---|
| Conditions: | Brain Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 10/3/2018 |
| Start Date: | May 16, 2017 |
| End Date: | June 2019 |
| Contact: | UC Cancer Institute Clinical Trials Office |
| Email: | cancer@uchealth.com |
| Phone: | 513-584-7698 |
A Phase 0/1 Exploratory Pharmacokinetic and Pharmacodynamics Study of Letrozole in Recurrent Gliomas
The purpose of this study is to determine the ability of letrozole to penetrate the blood
brain barrier and concentrate in gliomas.
brain barrier and concentrate in gliomas.
Inclusion Criteria:
- Recurrent brain glioma with plan for resection or biopsy.
- ECOG 0-2
- Adequate labs
Exclusion Criteria:
- Receiving other investigational agents.
We found this trial at
1
site
University of Cincinnati The University of Cincinnati offers students a balance of educational excellence and...
Click here to add this to my saved trials
